PainChek expands into UK market
Peter Milios: I’m Peter Milios from the Finance Use Network, and today I’m talking with PainChek. PainChek, trading under the ASX Code PCK with a market capitalization of 45 million, is the developer of the world’s first smart-based pain assessment and monitoring application. Today we are talking to the company’s chief executive officer, Philip Daffas. Philip, welcome back to the network.
Philip Daffas: Thank you, Peter. Lovely to be here again.
Peter Milios: Philip, to start, could you give us some context about PainChek for those who may not be acquainted with the company?
Philip Daffas: Certainly, and apparently, to bring it back to basics, pain assessment, as we all know, is very difficult to do, but it’s very difficult to do, especially for those who can’t reliably verbalize their pain. That includes people, one extreme, elderly people living with dementia and cognitive impairment who have lost those communication skills. On the other extreme, very young children who are pre-verbal who haven’t built those skills. PainChek specializes in building tools, medical devices, in the form of an app that actually provides a pain assessment technology to assess pain for those vulnerable people and therefore to improve the medication for them